MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients

Objective: Tyrosine kinase inhibitors (TKIs) are used for the treatment of metastatic differentiated (DTC), poorly differentiated (PDTC) and medullary (MTC) thyroid cancer. Several adverse events (AEs) have been reported in almost all patients (pts) treated with TKIs. One of the less known AE relate...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Valerio, Laura, Matrone, Antonio, Agate, Laura, Bottici, Valeria, Viola, David, Cappagli, Virginia, Giani, Carlotta, Molinaro, Eleonora, Elisei, Rossella
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Thyroid
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209016/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1647
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares